Skip to main content

Table 2 The antibiotic sensitivities of A. baumannii isolates and screening results of OXA genes

From: Molecular characterisation and control of Acinetobacter baumanniiisolates resistant to multi-drugs emerging in inter-intensive care units

  SAM TZP CAZ FEM AMK GAT TOB NET CIPX TGC CST SXT IPM MEM
Sensitive n (%) 8 (7.3) 3 (2.8) 19 (17.4) 2 (1.7) 19 (17.4) 85 (77.9) 86 (78.9) 93 (85.3) 2 (1.8) 109 (100) 109 (100) 69 (63.3) 7 (6.4) 6 (5.5)
Intermediate n (%) 22 (20.2) 0 7 (6.4) 1 (1.1) 4 (3.7) 3 (2.8) 0 1 (1.0) 0 0 0 0 2 (1.7) 1 (1.0)
Resistant n (%) 79 (72.5) 106 (97.2) 83 (76.2) 106 (97.2) 86 (78.9) 21 (19.3) 23 (21.1) 15 (13.7) 107 (98.2) 0 0 40 (36.7) 100 (91.9) 102 (93.5)
bla OXA-51-like All isolates (n=109) were positive
bla OXA-23-like 103 of isolates were positive
bla OXA-24-like All negative
bla OXA-48-like All negative
bla OXA-58-like All negative
  1. SAM: Ampicillin-sulbactam, TZP: Piperacillin-tazobactam, CAZ: Ceftazidime, FEM: Cefepime, AMK: Amikacin, GAT: Gentamicin, TOB: Tobramicin, NET: Netilmicin.
  2. TGC: Tigecycline, CIPX(Ciprofloxacin),CST: Colistin, SXT: Trimethoprim-sulphamethoxazole, IPM: Imipenem, MEM: Meropenem.